These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21178064)

  • 21. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
    Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
    Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of N-butylscopolamine on SUV in FDG PET of the bowel.
    Sanghera B; Emmott J; Wellsted D; Chambers J; Wong WL
    Ann Nucl Med; 2009 Jul; 23(5):471-8. PubMed ID: 19444552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?
    Tochetto SM; Rezai P; Rezvani M; Nikolaidis P; Berggruen S; Atassi B; Salem R; Yaghmai V
    Radiology; 2010 Apr; 255(1):164-72. PubMed ID: 20308454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
    Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
    Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
    Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images.
    Han YM; Kim YC; Park EK; Choe JG
    AJR Am J Roentgenol; 2010 Jul; 195(1):223-8. PubMed ID: 20566820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients.
    Ali MA; El-Abd E; Morsi M; El Safwany MM; El-Sayed MZ
    Eur J Hybrid Imaging; 2023 Oct; 7(1):19. PubMed ID: 37840056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions.
    Lupi A; Zaroccolo M; Salgarello M; Malfatti V; Zanco P
    Ann Nucl Med; 2009 Feb; 23(2):191-6. PubMed ID: 19225943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
    Szyszko T; Al-Nahhas A; Canelo R; Habib N; Jiao L; Wasan H; Pagou M; Tait P
    Nucl Med Commun; 2007 Jan; 28(1):15-20. PubMed ID: 17159544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).
    Narita A; Shiomi S; Katayama Y; Yamanaga T; Daisaki H; Hamada K; Watanabe Y
    Radiol Phys Technol; 2016 Jul; 9(2):170-7. PubMed ID: 26873140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.
    Yu J; Li X; Xing L; Mu D; Fu Z; Sun X; Sun X; Yang G; Zhang B; Sun X; Ling CC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1468-74. PubMed ID: 19464822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic and splenic
    Keramida G; Roldao Pereira L; Kaya G; Peters AM
    Clin Physiol Funct Imaging; 2020 Mar; 40(2):99-105. PubMed ID: 31769591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.